A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer by Chang, Ellen T. et al.
 




(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Chang, Ellen T., Paolo Boffetta, Hans-Olov Adami, Philip Cole,
and Jack S. Mandel. 2014. “A critical review of the
epidemiology of Agent Orange/TCDD and prostate cancer.”




Accessed February 17, 2015 3:01:46 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347459
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAREVIEW
A critical review of the epidemiology of Agent Orange/TCDD
and prostate cancer
Ellen T. Chang • Paolo Boffetta • Hans-Olov Adami •
Philip Cole • Jack S. Mandel
Received: 12 February 2014/Accepted: 16 June 2014/Published online: 27 July 2014
  The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract To inform risk assessment and regulatory deci-
sion-making, the relationship between 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (TCDD) and prostate cancer requires
clariﬁcation. This article systematically and critically reviews
the epidemiologic evidence on the association between expo-
sure to TCDD or Agent Orange, a TCDD-contaminated her-
bicide used during the Vietnam War, and prostate cancer risk.
Articles evaluated include 11 studies of three cohorts, four
case–control or cross-sectional studies, and three case-only
studies of military veterans with information on estimated
AgentOrangeorTCDDexposure;13studiesofsevencohorts,
one case–control study, and eight proportionate morbidity or
mortality studies of Vietnam veterans without information on
Agent Orange exposure; 11 cohort studies of workers with
occupational exposure to TCDD; and two studies of one
community cohort with environmental exposure to TCDD.
The most informative studies, including those of Vietnam
veteransinvolvedinAgentOrangesprayingorotherhandling,
herbicide manufacturing or spraying workers with occupa-
tional TCDD exposure, and community members exposed to
TCDDthroughanindustrialaccident,consistentlyreportedno
signiﬁcant increase in prostate cancer incidence or mortality.
OnlysomepotentiallyconfoundedstudiesofVietnamveterans
compared with the general population, studies with unreliable
estimates of Agent Orange exposure, and analyses of selected
subgroups of Vietnam veterans reported positive associations.
Overall, epidemiologic research offers no consistent or con-
vincing evidence of a causal relationship between exposure to
Agent Orange or TCDD and prostate cancer. More accurate
exposure assessment is needed in large epidemiologic studies
to rule out a causal association more conclusively.
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Introduction
Prostate cancer is the most common non-skin malignancy
in U.S. men and the second most common cancer in men
globally [1]. Despite extensive clinical and epidemiologi-
cal research, the causes of prostate cancer remain elusive.
Several environmental agents have been proposed to con-
tribute to prostate carcinogenesis, including nutritional
factors such as lycopene [2], tobacco smoking [3], and
synthetic endocrine-disrupting chemicals [4]. In particular,
exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
has been proposed as a possible cause of prostate cancer
[5]. In 1997 and 2012, the International Agency for
Research on Cancer (IARC) classiﬁed TCDD as an
established human carcinogen (IARC group 1) [6, 7].
According to the IARC evaluation, the strongest evidence
of an increased risk of cancer in humans is for all cancers
combined, while ‘‘a positive association has been
observed’’ for soft-tissue sarcoma, non-Hodgkin lym-
phoma, and lung cancer [7]. The classiﬁcation of TCDD as
a group 1 carcinogen is based in large part on mechanistic
data showing tumor promotion through modiﬁcation of cell
replication and apoptosis mediated through the aryl
hydrocarbon (Ah) receptor and related signaling pathways
and responses, which are conserved across species [6, 7].
Results regarding the association between TCDD expo-
sure and risk of prostate cancer were presented from only
three epidemiologic studies reviewed in the earlier IARC
evaluation in 1997 [6]; none of these detected a signiﬁcant
increase in prostate cancer incidence or mortality among
workers potentially exposed to TCDD [8–10]. The 2012
IARC review, which addressed new information published
sincethe1997reviewaspartofabroadupdateonallgroup1
carcinogens, did not mention prostate cancer as an endpoint
considered in relation to TCDD [7]. Other national and
international agencies that have reviewed the epidemiologic
evidence on TCDD and cancer, including some that classi-
ﬁed TCDD as ‘‘carcinogenic to humans’’ [11], ‘‘at least
‘likelytobecarcinogenictohumans’’’[12],or‘‘knowntobe
a human carcinogen’’ [13], have likewise largely been silent
on prostate cancer [11,12, 14–16]. Only one of these reports
[15] cited any results for prostate cancer, noting that this
outcome was not increased above expectation in a pooled
international cohort of workers exposed to phenoxy herbi-
cides and chlorophenols contaminated with TCDD [17].
Thus, although epidemiologic studies of the association
between TCDD and risk of all cancers and certain site-
speciﬁc cancers have been critically reviewed, albeit with
conﬂicting conclusions [18–22], the relationship of TCDD
withprostatecancerriskhasnotyetbeenwellcharacterized.
Since1991,theU.S.InstituteofMedicine(IOM)hasbeen
congressionally mandated to conduct a comprehensive
evaluation, updated biennially, of scientiﬁc and medical
information related to health outcomes associated with
Agent Orange and other herbicides used for defoliation and
crop destruction during the Vietnam War between 1962 and
1971[23].AgentOrangeisadefoliantmadefromequalparts
of the phenoxy herbicides 2,4-dichlorophenoxyacetic acid
(2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), the
latterofwhichiscontaminatedwithTCDDasabyproductof
the manufacturing process. Since its initial report in 1994,
the IOM committee has repeatedly concluded that there is
‘‘limited/suggestive evidence of an association’’ between
herbicides and prostate cancer—that is, that ‘‘[e]vidence is
suggestive of an association between herbicides and the
outcome but is limited because chance, bias, and con-
founding could not be ruled out with conﬁdence’’ [23–32].
Understanding the association between TCDD and
prostate cancer is important for risk assessment and regu-
latory decision-making, and is also of public health rele-
vance given that low-dose exposure to TCDD is ubiquitous
and prostate cancer is one of the most common malig-
nancies worldwide. Furthermore, recent articles focusing
on the relationship between Agent Orange exposure and
prostate cancer risk have attracted attention to this issue
[33, 34]. Therefore, this article aims to provide a detailed
review of the epidemiologic evidence on Agent Orange/
TCDD and prostate cancer.
Epidemiology of prostate cancer
More than 1,100,000 new cases of prostate cancer and
300,000 prostate cancer deaths occur each year worldwide
[1]. The disease primarily affects older men, with a median
age at diagnosis around age 70 years. Incidence rates vary
by more than 30-fold internationally, with the highest rates
found in Australia and New Zealand, northern and western
Europe, and North America, and the lowest rates found in
668 E. T. Chang et al.
123southern and eastern Asia and North Africa [1]. Much of
the excess incidence in economically developed regions,
along with the rapid rise in prostate cancer incidence in the
early 1990s, is attributed to the widespread practice of
prostate-speciﬁc antigen (PSA) testing to detect asymp-
tomatic tumors, many of which are clinically indolent and
would not otherwise become clinically apparent [35, 36].
The high proportion of such latent disease makes prostate
cancer particularly difﬁcult to study epidemiologically.
That is, any factor that affects diagnostic intensity and
particularly PSA testing will inevitably affect observed
prostate cancer incidence, making it difﬁcult to distinguish
between factors that inﬂuence disease development and
those that inﬂuence disease detection.
The general epidemiology of prostate cancer has been
reviewed in other publications [37–41]. The only estab-
lished risk factors for prostate cancer are older age, family
history of the disease (which confers a twofold to fourfold
increased risk in ﬁrst-degree relatives), certain genetic
variants, and race, with higher risk among men of black/
sub-Saharan African origin than men of white/European
origin, and lowest risk among those of Asian origin. Other
reviews cited in this section are focused on speciﬁc
potential risk factors for prostate cancer. A few rare genetic
mutations, including variants in the tumor suppressor gene
BRCA2, the DNA repair genes PALB2, BRIP1, CHEK2,
and NBS1, and the transcription factor gene HOXB13,
appear to confer a ‘‘moderate’’ excess risk of prostate
cancer, and 76 common variants that confer a ‘‘small’’
excess risk have been identiﬁed by genome-wide associa-
tion studies thus far, together explaining approximately
30 % of the familial risk of prostate cancer [42].
Diet has been extensively studied with respect to pros-
tate cancer risk, with largely inconsistent ﬁndings other
than inverse associations with lycopene and selenium and a
positive association with calcium—although even these
associations are not generally accepted as causal [2]. If
heavy alcohol consumption or tobacco smoking increases
prostate cancer risk—a question that is not settled—the
excess risk is probably below 30 % [3, 43]. The role of
energy balance, including physical activity, adiposity, and
levels of insulin and insulin-like growth factors, in prostate
cancer development has also been widely studied, with
suggestive but ultimately inconclusive results [2, 44]. A
farming occupation appears to be associated with increased
prostate cancer risk [45], although results are heteroge-
neous across studies, and the underlying explanations for
this association are unclear given inconsistent associations
with speciﬁc pesticides [46]. Higher circulating androgen
levels may be associated with increased prostate cancer
risk, but this apparently complex relationship is not yet
understood, and circulating testosterone levels measured in
epidemiologic studies may not reﬂect locally bioavailable
levels [47]. Infections have been inconsistently associated
with prostate cancer risk [48], including variable ﬁndings
for sexually transmitted infections, depending on the par-
ticular agent and method of detection [49]. Associations
with additional causes and biomarkers of inﬂammation also
imply an etiologic role of chronic intraprostatic inﬂam-
mation in prostate carcinogenesis [50]. No clear association
has been demonstrated between ionizing radiation [51],
vasectomy [52], or sexual behavior [53] and prostate can-
cer risk. Uncontrolled confounding by these unestablished
risk factors is not likely to be a major source of bias.
Instead, potential differences in diagnostic intensity are of
greater concern in most epidemiologic studies of prostate
cancer risk [54–56].
Methods
Studies included in this review were selected in a manner
similar to that previously described by Boffetta et al. [21]
in a review on TCDD and cancer. Speciﬁcally, this review
focuses on two sets of studies. The ﬁrst set comprises
studies that evaluated prostate cancer incidence or mor-
tality among Vietnam veterans who were involved in the
spraying or other handling of Agent Orange, or who
reported having been exposed to Agent Orange. Studies of
Vietnam veterans without information on Agent Orange/
TCDD exposure are also discussed brieﬂy to provide
context for the interpretation of studies with such exposure
information. The second set comprises studies of prostate
cancer incidence or mortality among workers involved in
the production or use of herbicides potentially contami-
nated by TCDD. We also evaluated studies of groups
exposed via industrial accidents to herbicides or interme-
diates potentially contaminated with TCDD.
We did not review studies of workers exposed to herbi-
cides not contaminated by TCDD, agents contaminated by
polychlorinated dibenzo-para-dioxins other than TCDD, or
unspeciﬁedorpoorlyspeciﬁedcombinationsofpesticidesor
herbicides.Wealso excluded studies of occupational groups
with potential but unmeasured exposure to TCDD, such as
farmers, forestry workers, pulp and paper workers, chloral-
kali workers, waste incinerator workers, steel mill workers,
and ﬁshermen, because no epidemiologic studies of these
groups have aimed speciﬁcally at estimating the health
effectsofTCDDasdistinctfromotherpotentiallyhazardous
occupational exposures. Furthermore, average TCDD
exposure levels in these groups of workers have been shown
or are expected to be relatively low [6]. We also excluded
ecologic studies that lack individual-level assessment of
exposures and outcomes. Studies of PSA levels in the
absence of malignancy (e.g., [57]) or after prostate cancer
diagnosis (e.g., [58]) were not considered.
Epidemiology of Agent Orange/TCDD and prostate cancer 669
123Relevant studies were identiﬁed from the IARC Mono-
graphs [6, 7], the IOM reports [23–32], and searches of the
PubMed database using keywords such as ‘‘dioxin,’’
‘‘TCDD,’’ ‘‘Agent Orange,’’ ‘‘Vietnam,’’ ‘‘herbicides,’’
‘‘cancer,’’ ‘‘malignancy,’’ ‘‘tumor,’’ ‘‘adenocarcinoma,’’
‘‘mortality,’’ ‘‘morbidity,’’ and ‘‘prostate.’’ We also iden-
tiﬁed additional studies from reference lists of included
articles.
Review of epidemiologic studies
The results of epidemiologic studies of veterans with
estimated exposure to Agent Orange/TCDD are provided in
Table 1. The results of epidemiologic studies of Vietnam
veterans without quantitative or qualitative estimates of
Agent Orange/TCDD exposure are provided in Table 2.
The results of epidemiologic studies of manufacturers and
sprayers of herbicides potentially contaminated with
TCDD are provided in Table 3, and the results of epide-
miologic studies of the Seveso, Italy, industrial accident
involving TCDD are provided in Table 4. All relevant
results are provided in the tables; for readability, only
selected illustrative results are provided in the text below.
To provide a visual overview of the results of all studies
that reported relative risk (RR) estimates for prostate can-
cer incidence, prevalence, or mortality in association with
Agent Orange/TCDD exposure or surrogates for exposure,
forest plots are provided in supplementary online ﬁgures.
Figure S1 shows the results of epidemiologic studies of
veterans with estimated exposure to Agent Orange/TCDD,
Figure S2 shows the results of epidemiologic studies of
Vietnam veterans without estimated exposure to Agent
Orange/TCDD, and Figure S3 shows the results of epide-
miologic studies of manufacturers and sprayers of herbi-
cides potentially contaminated with TCDD and studies of
the Seveso, Italy, industrial accident. To avoid skewing the
data by selectively displaying some results but not others,
all potentially relevant RR estimates for overall prostate
cancer are shown. Results are not shown for clinical sub-
groups of prostate cancer. Summary RRs are not calculated
to avoid presenting a single non-representative RR from
each study, obscuring information on potential exposure–
response trends, inappropriately equating disparate expo-
sures such as measured serum TCDD levels and self-
reported Agent Orange exposure, and overstating the
homogeneity and statistical precision of results [59, 60].
It is important to emphasize that this graphic display of
results does not take study quality into account, and it does
not more heavily weight studies that used more valid
measures of TCDD exposure. Therefore, the results shown
in the ﬁgures must be interpreted in light of the study
descriptions presented in the text and tables.
Studies of veterans with estimated Agent Orange/
TCDD exposure
Air Force Health Study
The Air Force Health Study is a prospective matched
cohort study with up to 20 years of follow-up on 1,261
veterans of Operation Ranch Hand, the U.S. Air Force
program that conducted aerial spraying of herbicides,
including Agent Orange, in South Vietnam from 1962
through 1971 [61]. Due to their direct handling of herbi-
cides, Operation Ranch Hand veterans (hereafter referred
to as Ranch Hands) had the greatest potential for exposure
to Agent Orange/TCDD during the Vietnam War. The
unexposed comparison group in this study comprised
19,101 personnel assigned to aerial cargo missions in
Southeast Asia during the same time period. Up to 10
comparison subjects (a combined total of 10,133) were
initially matched to each Ranch Hand on date of birth, race,
rank, and military occupation during their duty in Southeast
Asia. Ranch Hands and one living comparison subject from
each matched set, with replacement of non-participating
comparison subjects, were invited to participate in periodic
physical examinations and questionnaires. TCDD levels
measured at the 1987 examination established that average
serum TCDD levels were higher in Ranch Hands than
comparison subjects within all strata of military occupation
and overall (Table 5).
The Air Force Health Study included two components: a
mortality study and a morbidity study. The mortality study
found no signiﬁcant difference in prostate cancer mortality
between Ranch Hands and comparison subjects as of 1993,
although few prostate cancer deaths were observed [stan-
dardized mortality ratio (SMR) = 3.18 [0.39–11.5]
1;2
deaths [62] (Table 1; Figure S1). With follow-up through
2000, prostate cancer mortality did not differ signiﬁcantly
between Ranch Hands and the general U.S. male popula-
tion (SMR = 0.70 [0.12–2.33]; 2 deaths) or between
comparison subjects and the general U.S. male population
(SMR = 0.77 [0.20–2.09]; 3 deaths) [63].
In the morbidity study, health conditions were identiﬁed
in Ranch Hands and matched comparison subjects through
physical examinations in 1982 (baseline), 1985, 1987,
1992, 1997, and 2002 (including digital rectal examination
in all years and PSA testing beginning in 1992), ques-
tionnaire responses that were validated by review of
medical records (which were also used to identify unre-
ported diagnoses, as possible), and death certiﬁcates [61].
1 Throughout this paper, relative risk point estimates are followed by
95 % conﬁdence intervals unless otherwise stated. Where conﬁdence
intervals were not reported by the authors, Fisher’s exact 95 %
conﬁdence intervals were calculated.













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Epidemiology of Agent Orange/TCDD and prostate cancer 701
123In a 1999 study, Ranch Hands were classiﬁed according to
serum TCDD levels measured in 1987 (for most subjects)
or 1992, extrapolated to the end of military service in
Southeast Asia under the assumption of a constant half-life
of 8.7 years, and categorized as ‘‘background’’ (B10 ppt),
‘‘low’’ (10–B94 ppt), or ‘‘high’’ ([94 ppt) [64]. As of 1997,
the adjusted odds ratio (OR) for prostate cancer in Ranch
Hands versus comparison subjects (33 cases) was 0.4
(0.1–0.8; 7 cases) in those with background serum TCDD
levels, 0.6 (0.3–1.5; 8 cases) in those with low serum
TCDD levels, and 0.7 (0.2–2.2; 4 cases) in those with high
serum TCDD levels, with no apparent dose–response trend
(P = 0.41) (Table 1; Figure S1).
In a reanalysis of this dataset, Kayajanian [65] reclas-
siﬁed TCDD exposure according to a body burden model
and—in a departure from the original study design—
compared observed prostate cancer incidence in all Air
Force Health Study participants (including Ranch Hands
and comparison subjects) against expected counts based on
U.S. national cancer incidence rates. Among white men,
the standardized incidence ratio (SIR) was consistently
elevated but did not change signiﬁcantly with higher esti-
mated TCDD body burden, whereas among black men, the
SIR was elevated but decreased signiﬁcantly with higher
estimated TCDD body burden (P\0.006, \0.004, and
\0.002 for various comparisons between higher and lower
exposure categories) (Table 1; Figure S1).
The Air Force Health Study was not designed to com-
pare Ranch Hands or comparison subjects with an external
group outside of Southeast Asia because the objective of
the study was ‘‘to determine the effects of exposure to
TCDD and not of service in Southeast Asia’’ [66]. Nev-
ertheless, in a 2004 study, the study investigators deviated
from the original study design by comparing cancer inci-
dence in Ranch Hands and comparison subjects with that
expected in the U.S. general population [63]. Deviation
from the original protocol is inappropriate if the a poste-
riori analysis is more likely to be biased and especially if it
is conducted in an effort to detect signiﬁcant results. In this
case, due to greater health care access among veterans [68],
comparisons of veterans with the general population were
more susceptible to upward bias due to differences in
diagnostic intensity than comparisons between Ranch
Hands and designated comparison subjects. Bias due to a
‘‘healthy serviceman’’ effect is not a major concern, given
the long latency period and advanced average age at onset
of prostate cancer [69]. All results reported for prostate
cancer in this study were for white men only.
Prostate cancer incidence as of 1999 was signiﬁcantly
higher than expected among both Ranch Hands
(SIR = 1.46 [1.04–2.00]; 36 cases) and comparison sub-
jects (SIR = 1.62 [1.23–2.10]; 54 cases), but no signiﬁcant

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Epidemiology of Agent Orange/TCDD and prostate cancer 707
123and comparison subjects (Pheterogeneity = 0.62) (Table 1;
Figure S1) [63]. Prostate cancer mortality was not signiﬁ-
cantly increased above expectation in either study group;
thus, the incidence ﬁnding was consistent with confound-
ing by diagnostic intensity. Borderline signiﬁcant differ-
ences in prostate cancer incidence between Ranch Hands
and comparison subjects were detected only in subgroup
analyses that compared Ranch Hands who spent 100 % of
their Southeast Asia service in Vietnam (SIR = 1.66
[1.00–2.60]) with comparison subjects who spent 0 % of
their Southeast Asia service in Vietnam (SIR = 0.59
[0.15–1.61]; Pheterogeneity = 0.08), or that were restricted to
veterans who spent a maximum of 2 years in Southeast
Asia (SIR for Ranch Hands = 1.54 [0.98–2.32]; SIR for
comparison subjects = 0.68; Pheterogeneity = 0.05). The
former association may have been inﬂuenced by differ-
ences in diagnostic intensity if health care usage was
greater among Vietnam than non-Vietnam veterans, as
suggested by some data [70]. Again, this comparison
marked a departure from the original Air Force Health
Study design and was more likely to be confounded than
contrasts between Ranch Hands and the original compari-
son subjects. The latter association, which was based on
68 % of Ranch Hands and 47 % of comparison subjects,
could have been due to selection bias resulting from con-
ditioning on a characteristic [71]—shorter duration of
military service—that was more frequent among Ranch
Hands and that could have been associated with greater
health care usage if, for example, servicemen served for a
shorter time due to health problems requiring medical
attention. The ﬁnding of a positive association restricted to
this subgroup is also counterintuitive, since shorter dura-
tion of service among Ranch Hands should have decreased
cumulative Agent Orange exposure.
In internal cohort analyses, serum TCDD levels were
extrapolated to the end of service in Vietnam assuming a
constant half-life of 7.6 years, and categorized as ‘‘back-
ground’’ (B10 ppt), ‘‘low’’ ([10–B118.5 ppt), or ‘‘high’’
([118.5 ppt) [63]. After restriction to veterans who spent at
most two years in Southeast Asia, the adjusted RR of
prostate cancer in Ranch Hands versus comparison subjects
increased with higher serum TCDD levels and was sig-
niﬁcantly elevated for those with high serum TCDD
(RR = 6.04 [1.48–24.61]; 5 cases) (Table 1). However,
log-transformed serum TCDD level itself was not signiﬁ-
cantly associated with prostate cancer risk in this subgroup
(RR = 1.48 [0.93–2.35]). In another analysis restricted to
Ranch Hands who spent 100 % of their Southeast Asia
service in Vietnam versus comparison subjects who spent
0 % of their Southeast Asia service in Vietnam, the RR for
high serum TCDD was 4.67 (0.75–29.07; 4 cases), with an
RR of 1.07 (0.64–1.78) per unit increase in log-transformed
serum TCDD level.
The authors noted that 53 of the 90 prostate cancer cases
(25 of 36 [69 %] among Ranch Hands and 28 of 54 [52 %]
among comparison subjects) were ‘‘diagnosed as a direct
result of the examinations’’ scheduled for the study, and
that ‘‘these data are consistent with the hypothesis that the
increased SIR for … prostate cancer might be at least
partially explained by the medical examinations that these
men received’’ [63]. These case numbers were sufﬁcient to
account for the excess prostate cancer incidence observed
among Ranch Hands versus the general population (36
cases observed vs. 24.71 expected) and among comparison
subjects versus the general population (54 cases observed
vs. 33.34 expected). The results of the internal analyses in
selected subgroups were potentially biased and difﬁcult to
interpret due to the reasons described above. Due to
insufﬁcient information, it is unclear whether discrepancies
in prostate cancer detection by the physical examination
were sufﬁcient to account for the observed differences
between subgroups.
Pavuk et al. [72] undertook an analysis of serum TCDD
levels measured in 1987 (mostly), 1992, or 1997 and
cancer risk among the comparison subjects only, and found
no signiﬁcant association between serum TCDD quartile
and prostate cancer incidence, with no apparent dose–
response trend (P = 0.72) (Table 1; Figure S1). However,
risk of prostate cancer increased with longer duration of
military service in Southeast Asia, with signiﬁcant excesses
Table 5 Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Air Force Health Study participants in 1987 (reproduced from Wolfe et al. [66])
Stratum Ranch Hands Comparison subjects
N Median (ppt) Range (ppt) N Median (ppt) Range (ppt)
Flying ofﬁcers (pilot) 247 7.3 0.0–42.6 239 4.7 0.0–18.5
Flying ofﬁcers (navigator) 63 9.3 1.1–35.9 53 4.5 2.2–7.9
Nonﬂying ofﬁcers 19 6.6 3.1–24.9 11 4.3 0.0–6.0
Flying enlisted personnel 152 17.2 0.0–195.5 137 4.0 0.0–12.7
Nonﬂying enlisted personnel 407 23.6 0.0–617.7 416 3.9 0.0–54.8
All personnel 888 12.4 0.0–617.7 856 4.2 0.0–54.8
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123among those who served for 2.1–3.7 years (RR = 2.2
[1.0–4.9]; 28 cases) or 3.7–16.4 years (RR = 2.4
[1.1–5.2]; 36 cases) versus 0.8–1.3 years (8 cases;
Ptrend = 0.003). These ﬁndings suggest that exposures in
Southeast Asia other than Agent Orange, or factors asso-
ciated with longer duration of military service, may be
responsible for observed associations with prostate cancer.
The correlation between serum TCDD levels and time
served in Southeast Asia was not reported, but it appeared
to be modest, based on a table showing quartiles of serum
TCDD by quartiles of years in Southeast Asia.
Finally, in the most recent analysis of prostate cancer
incidence in the Air Force Health Study, estimated 20-year
cumulative TCDD level was not signiﬁcantly associated
with prostate cancer risk [73]. The adjusted RR for low
cumulative TCDD in Ranch Hands (dichotomized at the
median of 443 ppt-years) versus comparison subjects was
1.02 (0.67–1.55; 31 cases), and that for high cumulative
TCDD in Ranch Hands was 1.22 (0.79–1.89; 28 cases)
(Ptrend = 0.42) (Table 1; Figure S1). A positive association
was detected among those who completed their last tour of
duty in Southeast Asia before 1969 (RR for high cumulative
TCDD = 2.27 [1.11–4.66]; 15 cases; Ptrend = 0.04) and
amongthosewhoservedforlessthantwoyears(RRforhigh
cumulative TCDD = 2.15 [1.03–4.48]; 14 cases;
Ptrend = 0.03).WhenRanchHandsandcomparisonsubjects
were analyzed separately, high versus low cumulative
TCDD was not signiﬁcantly associated with prostate cancer
risk in either group. Time served in Southeast Asia and last
year of duty also were not signiﬁcantly associated with
prostate cancer risk among Ranch Hands, but longer time
served in Southeast Asia (dichotomized at 789 days) was
signiﬁcantly associated with increased risk among compar-
ison subjects (RR = 2.18 [1.27–3.76]; 63 cases). Of note,
the distribution of Gleason score (disease grade indicating
likelihood of tumor spread) did not differ signiﬁcantly
betweenthe 62 RanchHandprostatecancercases andthe 89
comparison subject cases (P = 0.44). This ﬁnding suggests
that the two groups were equallyaffected by the detection of
low-grade disease by means of PSA testing.
Taken together, results from the Air Force Health Study
demonstrate no clear association between TCDD exposure
and prostate cancer risk. The higher risk in both Ranch
Hands and comparison subjects relative to the U.S. general
population, combined with the lack of a difference between
Ranch Hands and comparison subjects, as well as the
absence of a signiﬁcant difference in prostate cancer mor-
tality between study subjects and the general population,
suggests that increased prostate cancer screening among
study participants compared with the general population
may be responsible for much or all of the observed excess
incidence. The positive associations within certain sub-
groups selected based on shorter duration of military service
or geographic location exclusively in or outside of Vietnam
were not well justiﬁed in advance, and were potentially
biased or due to chance if numerous subgroups were tested.
Methodological strengths and limitations of the Air
Force Health Study have been thoroughly discussed (e.g.,
[23, 32, 76–81]). Overall, exposure assessment is a major
strength of this study. The Air Force Health Study is the
only study of Vietnam veterans to have obtained serum
TCDD measurements for all subjects included in dose–
response analyses, thereby enabling identiﬁcation of the
most highly-exposed subjects. These measurements dem-
onstrated that Ranch Hands were sufﬁciently exposed to
TCDD that serum levels were detectable more than
15 years after their last service in Vietnam. Moreover, their
TCDD levels exceeded those among U.S. Army Chemical
Corps veterans (discussed below) and U.S. Army ground
combat troops who served in heavily sprayed areas of
Vietnam (among whom serum TCDD levels were indis-
tinguishable from troops with no service in Vietnam or
even the general public [82]). Although the estimates of
past TCDD exposure could have been based on some
incorrect assumptions, the substantial difference in average
serum TCDD concentrations between Ranch Hands and
comparison subjects indicates that the impact on estimated
associations was probably modest. Thus, the persistently
elevated serum TCDD levels in the majority of Ranch
Hands make this group the primary bellwether for the
health effects of Agent Orange/TCDD.
Another key strength of this study is the inclusion of a
comparison group of veterans matched on age, race, rank,
and military occupation and controlling for military service
involving aircraft missions in Southeast Asia, thereby
making the groups equivalent in terms of ‘‘combat-induced
physiologic,psychophysiologic,andotherrelated morbidity
and mortality disorders,’’ as well as ‘‘the effects of alcohol
consumption, the use of chemoprophylactic and/or illicit
drugs, and the acquisition of tropical diseases associated
with life in [Southeast Asia]’’ [83]. Notably, this strength
was nulliﬁed in external comparisons of Ranch Hands with
the general population, as conducted by Akhtar et al. [63].
With the exception of those analyses, given the unique
advantages of the Air Force Health Study, its results provide




Army Chemical Corps study
Membersof22U.S.ArmyChemicalCorpsunitsassignedto
South Vietnam between1966 and 1971 were responsible for
the storage, handling, mixing, application, and equipment
maintenance of tear gas, burning agents, and herbicides,
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ities, Army Chemical Corps personnel in Vietnam were
assumed to have had, on average, much higher levels of
Agent Orange exposure than other veterans (excluding
Ranch Hands). Among Army Chemical Corps veterans,
serum TCDD levels were highest in those who were sta-
tioned in Vietnam and reported having sprayed herbicides
(mean = 4.3 ppt lipid-corrected, range 0.5–85.8), followed
by herbicide sprayers not stationed in Vietnam (3.1,
0.8–9.6), non-sprayers stationed in Vietnam (2.70,
0.6–27.7), and non-sprayers not stationed in Vietnam (2.1,
0.4–12.5) [85]. Levels of six other dioxin congeners did not
differ signiﬁcantly between Vietnam sprayers and non-
Vietnam non-sprayers [86]. In an initial cohort of 894 Army
Chemical Corps members assigned to Vietnam, no prostate
cancer deaths had occurred as of the end of 1987 (expected
number of deaths not stated, but probably near zero), and no
incident prostate cancers were identiﬁed from the U.S.
Department of Veterans Affairs (VA) Agent Orange Reg-
istry (which collects information on veterans who claim
Agent Orange exposure and undergo a special physical
examination at a VA medical center) as of 1988 or VA
inpatient discharges as of 1986 [83].
Subsequently the cohort was expanded to include 2,872
male U.S. Army veterans with at least one assignment to the
Chemical Corps in Vietnam, and a comparison group of 2,737
male U.S. Army veterans last discharged from the Chemical
Corps but never assigned to Southeast Asia [87]. Through
2005,ﬁvedeathsfromprostatecancerhadoccurredinVietnam
Chemical Corps members versus two in comparison subjects,
resulting in an adjusted RR of 1.02 (0.19–5.64) (Table 1;
Figure S1). Compared with the general U.S. population, the
SMR for prostate cancer was 1.05 (0.34–2.45) among Chem-
ical Corps members who served in Vietnam and 0.95
(0.12–3.43) among those who served outside Southeast Asia.
Despite its small size and lack of quantitative exposure
estimatesinVietnamChemicalCorpsmembers,thisstudyis
strengthened by its focus on Vietnam veterans with known
militaryexposuretoherbicides,itslongandhighlycomplete
follow-up, and its use of a comparable group of veterans
without military service in Southeast Asia (and, conse-
quently, little chance of exposure to Agent Orange). Due to
high survival rates, prostate cancer mortality is not a close
proxy for incidence, but associations with prostate cancer
mortality are less susceptible to diagnostic bias. Overall,
these ﬁndings suggest little to no excess of prostate cancer
mortality in Army Chemical Corps veterans who served in
Vietnam, relative to their peers and U.S. males in general.
Other studies
Other epidemiological studies of prostate cancer have
relied in part on self-reported exposure to Agent Orange,
which has been shown not to be a valid indicator of serum
TCDD levels [81]. Many of these studies also used the
VA’s presumptive deﬁnition of Agent Orange exposure,
which classiﬁes veterans as exposed if they served for any
length of time in Vietnam (including brief visits ashore and
service on inland waterways) between January 9, 1962, and
May 7, 1975, or in or near the Korean demilitarized zone
anytime between April 1, 1968, and August 31, 1971 [88].
This deﬁnition of exposure is inconsistent with consider-
able evidence that ground troops in Vietnam were not
appreciably exposed to Agent Orange [89]. Therefore, a
major concern in such studies is exposure misclassiﬁcation,
which may differ between prostate cancer cases and non-
cases if cases are more likely to report past exposure or to
undergo a VA Agent Orange Registry health exam, or if
veterans designated as exposed are more likely to undergo
prostate cancer screening and/or diagnostic work-up.
Importantly, such misclassiﬁcation should not be assumed
to be non-differential, and even exactly non-differential
misclassiﬁcation can often lead to overestimated RRs [90,
91]. Overall, given the unreliability of self-reported and
geography-based Agent Orange exposure, the results of
these studies cannot be interpreted as valid estimates of the
association between Agent Orange/TCDD exposure and
prostate cancer risk.
Of 400 consecutive veterans referred for prostate needle
biopsy at the Palo Alto, California, VA medical center in
1998–2000, 32 (8 %) self-reported on a standard registra-
tion questionnaire that they had been exposed to Agent
Orange [5]. The 32 exposed patients were age-matched to a
comparison group of 96 unexposed subjects selected from
the remaining 368 veterans who did not report Agent
Orange exposure, and prostate cancer incidence and related
characteristics were compared between the groups. Mili-
tary service in Vietnam was not required for eligibility. No
signiﬁcant difference was detected in the proportion of
exposed patients (40.4 %) versus unexposed patients
(34.6 %) who were subsequently diagnosed with prostate
cancer (P = 0.15), nor did the proportion of cases with
Gleason score C7 differ signiﬁcantly by exposure status
(Table 1). Mean PSA levels, overall frequency of referral
for prostate biopsy, and mean length of cancer in biopsy
also did not vary between the exposed and unexposed
groups, whereas exposed patients were, on average, 5 years
younger at referral for prostate biopsy than the overall
group of 400 referred patients (P = 0.01), suggesting
potential differences in diagnostic intensity by exposure
status. On the other hand, authors reported that an average
of 1.07 % of exposed patients at their facility were referred
annually for prostate biopsy, compared with 1.33 % of
unexposed patients, potentially resulting in modest under-
estimation of the association due to diagnostic bias. Prob-
able exposure misclassiﬁcation could have biased estimates
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Overall, this study provides no support for an increased risk
of overall or high-grade prostate cancer in veterans who
self-report exposure to Agent Orange.
In a VA hospital-based case–control study set in Ann
Arbor, Michigan, investigators compared self-reported
Agent Orange exposure, as recorded in the computerized
medical record, between 47 prostate cancer cases diag-
nosed in 2000–2001 and born between 1935 and 1953 (to
‘‘encompass men who were the appropriate age for
potential military service in Vietnam’’) and 142 age-mat-
ched controls selected randomly from the hospital’s gen-
eral medicine clinic [92]. The proportion of cases (29.8 %)
and controls (34.5 %) who reported military service in
Vietnam did not differ signiﬁcantly. However, the pro-
portion who reported Agent Orange exposure was non-
signiﬁcantly higher among cases (23.4 %) than controls
(12.0 %) (adjusted OR = 2.06 [0.81–5.23]) (Table 1;
Figure S1). The proportion of non-Vietnam veterans who
reported Agent Orange exposure was not stated. Mean age
at diagnosis, Gleason score, and pathologic stage did not
differ signiﬁcantly between prostate cancer cases with and
without Agent Orange exposure. Whether Agent Orange
exposure was self-reported before or after prostate cancer
diagnosis was unknown, raising the possibility of differ-
ential exposure misclassiﬁcation due to recall bias. The
authors also raised the possibility of selection bias due to
exclusion of subjects with missing data, and noted the
small number of subjects. Thus, this methodologically
weak study offers no reliable evidence of any association
between self-reported Agent Orange exposure and prostate
cancer risk in veterans.
Another VA study based in northern California evalu-
ated prostate cancer incidence ascertained from electronic
medical records between 1998 and 2006 among 6,214
Vietnam veterans who were classiﬁed as exposed to Agent
Orange (239 cases) and 6,930 Vietnam veterans classiﬁed
as unexposed (124 cases) [34]. Exposure status was based
on self-reported Agent Orange exposure on the initial
application for medical beneﬁts and having been stationed
in ‘‘known areas that were sprayed with Agent Orange
during 1962 through 1971’’ (i.e., 27–36 years prior to case
ascertainment). The deﬁnition of ‘‘known areas’’ was not
further elaborated, making it unclear whether, for example,
the entire country of Vietnam was considered to be an area
sprayed with Agent Orange. Seven veterans who initially
claimed no exposure to Agent Orange but changed their
self-reported exposure status after developing prostate
cancer were excluded, whereas 38 patients who ﬁrst
reported Agent Orange exposure after prostate cancer
diagnosis were retained in the analysis; the remaining 231
cases who reported Agent Orange exposure apparently did
so before prostate cancer diagnosis. The timing of exposure
ascertainment relative to prostate cancer diagnosis or study
entry was unclear for the remaining study subjects.
The frequency of PSA screening, the proportion of
patients evaluated by a urologist for elevated PSA, and the
proportion who subsequently underwent biopsy did not
differ signiﬁcantly by exposure status (Table 1)[ 34]. Risk
of prostate cancer was signiﬁcantly higher among exposed
than unexposed veterans (adjusted OR = 4.83 [3.42–6.81])
(Figure S1). Adjusted ORs were also signiﬁcantly elevated
for high-grade prostate cancer (OR = 2.59 [1.30–5.13])
and metastatic prostate cancer at diagnosis (OR = 4.32
[1.34–13.96]). After excluding the 38 patients who repor-
ted Agent Orange exposure after prostate cancer diagnosis,
the association was substantially attenuated but still sta-
tistically signiﬁcant (OR = 1.85 [1.47–2.31]). Among the
prostate cancer cases, those classiﬁed as exposed to Agent
Orange, compared with those classiﬁed as unexposed, were
signiﬁcantly younger at diagnosis, had a higher mean
Gleason score, had a higher proportion of high-grade dis-
ease, were more likely to present with metastasis, and were
less likely to have a family history of prostate cancer, but
did not differ signiﬁcantly in clinical stage or PSA level. It
is somewhat surprising that the prevalence of PSA testing
and early-stage prostate cancer did not differ by exposure
status, given that veterans with self-reported exposure were
invited to undergo PSA testing and digital rectal exami-
nation; therefore, one might expect that exposed veterans
would be more likely to undergo these procedures than the
non-exposed. As expressed by Air Force Health Study
investigators [93], the ‘‘serious misclassiﬁcation of Agent
Orange/TCDD exposure’’ in the study by Chamie et al.
[34] ‘‘undermines the validity of their conclusions.’’
Moreover, the implausibly large estimated RRs suggest a
chance ﬁnding, potential selection bias, differential expo-
sure misclassiﬁcation, or other sources of bias, although
possible bias was difﬁcult to evaluate due to the ambiguous
description of study methods.
Among 2,720 veterans referred to the Portland, Oregon,
VA Medical Center for initial prostate biopsy and without a
history of prostate cancer, 203 were classiﬁed as exposed to
Agent Orange based on self-report at the time of hospital
enrollment (before prostate biopsy) or military service in
‘‘a location where [Agent Orange] was known to have been
used,’’ and the remaining 2,517 were classiﬁed as unex-
posed [33]. Subjects were not restricted to Vietnam or
Vietnam-era veterans. Prostate cancer was diagnosed in 74
(36 %) exposed veterans, including 40 (20 %) with Glea-
son score C7, and in 822 (33 %) unexposed veterans,
including 419 (17 %) with Gleason score C7.
Despite these relatively small differences by exposure
status, the adjusted OR for prostate cancer (vs. no prostate
cancer) in exposed versus unexposed veterans was 1.52
(1.07–2.13) (Table 1; Figure S1) [33]. Comparing high-
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OR was 1.75 (1.12–2.74), whereas that for low-grade dis-
ease was 1.24 (0.81–1.91). However, military service
branch was not signiﬁcantly associated with prostate can-
cer risk among veterans classiﬁed as exposed to Agent
Orange (results not shown by authors). Veterans with
reported Agent Orange exposure were signiﬁcantly
younger at biopsy than unexposed veterans, and age at
diagnosis was also younger and mean PSA (but not PSA
density) was lower in exposed than unexposed cases,
suggesting greater diagnostic intensity among exposed
subjects. Yet, the stronger association of Agent Orange
exposure with high-grade than low-grade disease runs
counter to the anticipated effect of diagnostic bias. The
high potential for exposure misclassiﬁcation based on self-
report and the VA’s presumptive deﬁnition of Agent
Orange exposure renders the results difﬁcult to interpret.
Thus, this study does not offer reliable evidence of a sig-
niﬁcant positive association between actual exposure to
Agent Orange and risk of high-grade prostate cancer.
A cross-sectional postal survey of 114,562 Korean vet-
erans of the Vietnam War (70 % of 164,208 contacted) was
conducted in 2004 to evaluate associations between Agent
Orange exposure and self-reported disease outcomes [94].
Agent Orange exposure was assessed based on self-report
(categorized as no, low, moderate, or high) and based on
the proximity of the military unit (battalion or company
based on self-reported survey data; division or brigade
based on Ministry of Defense records) to sprayed areas,
using the exposure opportunity index model E4 developed
by Stellman et al. [95].
Self-perceived exposure to Agent Orange was associ-
ated with an increased prevalence of prostate cancer (OR
for high vs. no exposure = 1.91 [1.69–2.16]) (Table 1;
Figure S1) [94]. However, modeled exposure to Agent
Orange was not signiﬁcantly associated with prostate
cancer, either at the division/brigade level or at the more
detailed battalion/company level (OR for low exposure vs.
none = 1.04 [0.92–1.17]; moderate exposure vs.
none = 1.04 [0.91–1.19]; high exposure vs. none = 1.11
[0.97–1.27]; Ptrend = 0.15). The combination of self-
reported exposure and self-reported disease is highly sus-
ceptible to information bias. The validity and reliability of
the exposure opportunity index model have also been
questioned on the basis of widely heterogeneous exposure
estimates [96]. Moreover, serum TCDD levels in 102
Korean Vietnam veterans in 2007 were poorly correlated
with either perceived self-reported exposure (r
2 = 0.129)
or proximity-based exposure (r
2 = 0.073 with division/
brigade-level exposure; r
2 = 0.159 with battalion/com-
pany-level exposure), nor with military unit (P = 0.67 for
support vs. combat unit as a predictor of serum TCDD
concentration) [97], and average TCDD levels
(mean = 1.2 ppt, median = 0.9 ppt) were lower than in
U.S. Vietnam-era veterans stationed in the continental U.S.
or Germany (mean = 4.1 ppt) [81]. Thus, the interpreta-
tion of perceived and modeled Agent Orange exposure in
this study is unclear, and the results do not support an
association between actual Agent Orange exposure and
prostate cancer in Korean Vietnam veterans.
Three other studies of prostate cancer in veterans com-
pared patient and disease characteristics between prostate
cancer patients with and without reported Agent Orange
exposure (Table 1)[ 98–100]. These studies do not address
the association between Agent Orange exposure and
prostate cancer risk. However, they can provide informa-
tion on differences in diagnostic intensity between exposed
and unexposed veterans (although not between veterans
and the general population), and address the hypothesis
raised by Ansbaugh et al. [33] and Chamie et al. [34] that
Agent Orange exposure is associated with higher-grade
disease.
At a West Virginia cancer center between 1995 and
2005, 29 Vietnam veterans with Agent Orange exposure
determined by eligibility for VA beneﬁts and 52 Vietnam
veterans without Agent Orange exposure underwent per-
manent brachytherapy for prostate cancer [100]. Those
with Agent Orange exposure were signiﬁcantly younger at
the time of implantation and had signiﬁcantly higher pre-
treatment PSA, but did not differ signiﬁcantly in terms of
Gleason score, percent positive biopsies, prostate volume,
clinical stage, perineural invasion, or risk group (based on a
combination of PSA, Gleason score, and stage), indicating
no signiﬁcant difference in diagnostic intensity or disease
characteristics by VA-designated Agent Orange status.
Among 1,495 veterans at four VA medical centers who
underwent radical prostatectomy for prostate cancer in
1988–2007, including 206 classiﬁed in the electronic
medical record as having been exposed to Agent Orange
and 1,289 classiﬁed as unexposed, exposed patients were
signiﬁcantly more likely to be younger at the time of rad-
ical prostatectomy, have lower-stage disease, and have a
lower preoperative PSA level [99]. However, no signiﬁcant
group differences were observed in the distribution of
biopsy or pathological Gleason score, the prevalence of
lymph node metastasis, or the odds of having high-grade
disease, positive surgical margins, or seminal vesicle
invasion. These results may suggest heightened surveil-
lance for prostate cancer among veterans reporting Agent
Orange exposure, but no signiﬁcant difference in Gleason
score or other disease characteristics.
Among 93 veterans at the Augusta, Georgia, VA med-
ical center who underwent radical prostatectomy for pros-
tate cancer in 2005–2009, those classiﬁed in the electronic
medical records (based on self-report and military records
conﬁrming military service ‘‘in an area in which [Agent
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time of radical prostatectomy than those classiﬁed as
unexposed, and were less likely to have positive surgical
margins, but did not differ signiﬁcantly in terms of pre-
operative PSA level, prostate volume, biopsy or prosta-
tectomy Gleason score, tumor pathological stage,
extracapsular extension, seminal vesicle invasion, lymph
node metastasis, or subsequent mortality (with a median
follow-up of 64 months) [98]. Results were similar when
patients were classiﬁed as having high or low dioxin-like
toxic equivalency values measured in subcutaneous adi-
pose tissue. Although the ﬁndings regarding age at pro-
statectomy, preoperative PSA level, and tumor stage differ
from those of Shah et al. [99], with less evidence of dis-
parate diagnostic intensity, they again suggest no signiﬁ-
cant relationship between self-reported/geography-based
Agent Orange exposure and clinical disease characteristics.
In summary, three VA hospital-based studies in the U.S.
[33, 34, 92] and a cross-sectional study of prostate cancer
prevalence in Korea [94] reported a signiﬁcant positive
association between self-reported or geography-based
Agent Orange exposure and prostate cancer, whereas one
VA-based study did not [5]. Also, two studies found a
signiﬁcant positive association between self-reported or
geography-based Agent Orange exposure and risk of high-
grade prostate cancer [33, 34], whereas ﬁve did not [5, 92,
98–100]. Only the Korean investigators attempted to vali-
date self-reported Agent Orange exposure by comparison
with serum TCDD levels, and they found no correlation
between the two [97]. The same lack of association
between serum TCDD levels and self-reported or proxim-
ity-based estimated Agent Orange exposure has been
demonstrated in U.S. veterans [81]. In light of the high
probability of severe exposure misclassiﬁcation, these
studies cannot reliably be interpreted as unbiased analyses
of associations with actual Agent Orange exposure. Com-
bined with concerns about potential recall bias, selection/
diagnostic bias, and other methodological problems, the
unknown interpretation of self-reported Agent Orange
exposure renders these studies essentially uninformative
with regard to the question of a causal effect of Agent
Orange or TCDD on prostate cancer.
Studies of Vietnam veterans without estimated Agent
Orange/TCDD exposure
In its Veterans and Agent Orange updates, the IOM
Committee takes into consideration studies of Vietnam
veterans that lack estimates of exposure to Agent Orange/
TCDD or restriction to a subgroup of veterans known to
have had high potential for Agent Orange exposure [23–
32]. As stated in the most recent (2012) update, Vietnam
veterans ‘‘are assumed to have had a higher probability of
exposure to the [chemicals of interest] than people who did
not serve in Vietnam, whether or not their individual
exposures are characterized beyond the mere fact that they
were deployed to Vietnam’’ [23]. However, comparisons of
all Vietnam veterans with veterans who served outside of
Southeast Asia must be interpreted with caution due to the
high potential for misclassiﬁcation of Agent Orange
exposure, as well as possible differences in diagnostic
intensity. As noted by the U.S. Centers for Disease Control
and Prevention (CDC), differences between Vietnam and
non-Vietnam veterans could include ‘‘psychological stres-
ses of war, possible exposure to various infectious diseases
prevalent in Vietnam, possible misuse of drugs and alco-
hol, and possible exposure to the defoliant Agent Orange,
as well as many unknown exposures’’ [101]. Such expo-
sures might contribute to increased health care usage and,
hence, diagnostic intensity among Vietnam veterans [102–
104]. Comparisons with general populations are especially
susceptible to this type of bias due to the generally greater
health care access and/or usage among veterans than non-
veterans [68, 105]. Thus, associations with military service
in Vietnam cannot reliably be attributed to exposure to
Agent Orange/TCDD, and such studies are only brieﬂy
discussed here because they are not informative about
causal associations between Agent Orange/TCDD expo-
sure and prostate cancer risk.
The Government of Australia conducted a series of
retrospective cohort studies comparing Australian veterans
of the Vietnam War with either conscripts who served only
in Australia or the general population of Australia. Aus-
tralian military personnel in Vietnam were mostly stationed
in Phuoc Tuy Province, which was not heavily sprayed
with Agent Orange; thus, the average exposure of Austra-
lian troops to Agent Orange was probably low, if any
[106]. Analyses that compared approximately 19,000
Australian male National Service conscripts who served in
Vietnam with approximately 25,000 who served only in
Australia found no signiﬁcant difference in genitourinary
cancer mortality (RR = 0.7 [0.2–3]) [107], prostate cancer
incidence (RR = 1.05 [0.75–1.48]) [109], or prostate
cancer mortality (RR = 0.00 [0.00–1.41]; 0 vs. 5 deaths)
between the groups (Table 2; Figure S2).
Other epidemiologic studies of Australian veterans of
the Vietnam War were based on comparisons between
Vietnam veterans and the general Australian population,
rather than veterans stationed elsewhere. Although most
(but not all [109]) of these analyses found signiﬁcant ele-
vations in prostate cancer mortality [110, 112], prevalence
[114, 115], and incidence [116] among Australian Vietnam
veterans (Table 2; Figure S2), the excess cannot reliably be
attributed to any speciﬁc difference, including Agent
Orange or any other exposure, between veterans and non-
veterans.
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to evaluate the health consequences of military service in
Vietnam, where ‘‘Vietnam Experience’’ was used as ‘‘a
generic term for a wide range of health-inﬂuencing expo-
sures operating among those who served in the military in
Vietnam’’ [101]. The authors noted that ‘‘[t]hese factors are
unmeasured in this study; therefore, it is not possible to
examine directly their relation to mortality.’’ Postservice
mortality was compared between 9,324 Vietnam veterans
and 8,989 non-Vietnam veterans who served in Korea,
Germany, or the U.S. during the Vietnam era. As of the end
of 1983, no deaths from prostate cancer had occurred
among either Vietnam or non-Vietnam veterans (Table 2)
[101]. With additional follow-up through 2000, one death
from prostate cancer had occurred among Vietnam veter-
ans (mortality rate = 0.4 per 100,000 person-years), com-
pared with three deaths among non-Vietnam veterans (1.1
per 100,000 person-years) [117].
Notably, the CDC designed another study speciﬁcally to
evaluate the potential health effects of Agent Orange expo-
sure. However, this study was stopped after the exposure
assessment phase because serum TCDD levels measured in
1987 did not differ between veterans who were stationed in
the most heavily sprayed area of Vietnam (III Corps) and
veteranswhoservedinGermanyorthe U.S.duringthesame
years[81].Therefore,theauthors concluded that‘‘mostU.S.
Army ground troops who served in Vietnam were not
heavily exposed to TCDD, except perhaps men whose jobs
involvedhandlingherbicides’’[81],andthatinvestigationof
the potential health effects of Agent Orange exposure in
Vietnam veterans overall was infeasible.
A case–control study of 606 prostate cancer cases (61 %
participation) and 471 age-matched controls randomly
selected from electoral rolls (43 % participation)inWestern
Australia found a non-signiﬁcant increase in prostate cancer
risk in association between self-reported military service in
Vietnam (age-adjusted OR = 2.12 [0.88–5.06]) [118]. The
estimatedassociationwithVietnamservicewassimilarafter
adjusting for family history of prostate cancer or restriction
to patients with Gleason score C7 (Table 2; Figure S2).
Potential exposure to Agent Orange was not assessed, but as
stated by others [106], was likely to have been low or non-
existent among Australian troops in Vietnam.
Aretrospectivecohortstudyof2,783(outof3,322eligible)
male New Zealand veterans who served in Vietnam found no
signiﬁcant increase in prostate cancer incidence (SIR = 1.17
[0.98–1.39]) or mortality (SMR = 1.03 [0.55–1.76]) in com-
parison with the general New Zealand population (Table 2;
Figure S2) [119]. The majority of New Zealand troops served
alongside the Australian Army in Phuoc Tuy Province [119],
where Agent Orange spraying was limited [106].
Another retrospective cohort study of 185,265 male
Korean veterans of the Vietnam War detected a signiﬁcant
excess of prostate cancer incidence (SIR = 1.22
[1.02–1.46]) among all Vietnam veterans combined, com-
pared with the general male population of Korea (Table 2;
Figure S2) [120]. This excess was restricted to ofﬁcers
(SIR = 2.49 [1.93–3.21]), whereas enlisted soldiers and
non-commissioned ofﬁcers had a non-signiﬁcant deﬁcit of
prostate cancer incidence (SIRs = 0.85 [0.64–1.14] and
0.81 [0.51–1.29], respectively). Given that serum TCDD
levels did not vary by military rank [97], the prostate
cancer excess in ofﬁcers cannot reliably be attributed to
differences in Agent Orange exposure.
Proportionate mortality studies, which compare the
percentage of all deaths from a speciﬁed cause between an
exposed group of interest and an unexposed or general
population group, can give rise to misleading conclusions
about risk associations if they are used to compare groups
with different distributions of causes of death unrelated to
the exposure under study. Therefore, they do not provide
useful information about the association between Agent
Orange/TCDD exposure and prostate cancer risk, and they
are listed here only for the sake of completeness. No
published proportionate mortality or morbidity studies of
U.S. Vietnam versus non-Vietnam veterans, including
those in New York State [121], Wisconsin [122], West
Virginia [123], Michigan [124], Massachusetts [125, 126],
and the U.S. Army and Marine Corps [127, 128], found a
signiﬁcant excess of prostate cancer incidence or mortality
among Vietnam veterans (Table 2; Figure S2).
In summary, studies in Australia, New Zealand, and
Korea found that prostate cancer incidence, mortality, and/
or prevalence were higher in Vietnam veterans than in the
general population [110–116, 118–120], but comparisons
between Vietnam and non-Vietnam veterans in Australia
[107,109] and the U.S. [101,117,121,122,124–128] found
no such excess. Thus, the collective ﬁndings suggest that
military service speciﬁcally in Vietnam does not confer an
increasedriskofprostate cancerbeyondthat associatedwith
military service in general. These studies are limited by a
lack of detailed exposure assessment, poor control for
confounding by medical surveillance and other factors,
possible selection bias, and a low probability of direct or
indirect exposure to Agent Orange. Therefore, these stud-
ies—most of which found no signiﬁcant association
between Vietnam military service and prostate cancer—do
not provide informative results regarding the potential
causal effect of Agent Orange/TCDD on prostate cancer.
Studies of manufacturers and sprayers of herbicides
potentially contaminated with TCDD
The most informative industry-based studies of occupa-
tional exposure to TCDD concern two groups of workers:
chemical workers involved in the production of potentially
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pentachlorophenol), and sprayers of the same herbicides
(mainly 2,4,5-T). The review of the results on prostate
cancer risk among herbicide manufacturers and sprayers is
complicated by the fact that several partially overlapping
study groups have been included in various reports. Several
studies conducted in Europe and Oceania (most of which
had been reported separately) were combined in a pooled
analysis coordinated by IARC [129]; similarly, several US-
based studies (also reported separately) were combined in a
pooled analysis coordinated by the National Institute for
Occupational Safety and Health (NIOSH) [135]. The
results of the two pooled analyses were then reported in a
combined publication, which comprised four additional
German cohorts that also had been reported separately [17].
An update of the NIOSH pooled study was subsequently
reported [136], as well as updated analyses of some of the
individual plants. Similarly, updated analyses were repor-
ted for several of the studies included in the IARC pooled
study and one of the German cohorts.
In our review, we considered the combined publication
of the two pooled analyses [17], the NIOSH study update
[136], as well as the subsequent individual cohort studies
that provided more extensive results in terms of the size of
the study group or the duration of follow-up [137–144].
One additional study of herbicide production workers was
not included in any pooled analysis and is reviewed sepa-
rately [145]. The relevant studies are summarized in
Table 3, and are described relatively brieﬂy in this section
because of their uniformly statistically null results with
respect to prostate cancer. Although false-negative ﬁndings
are a possibility, whether due to insufﬁcient statistical
power, exposure misclassiﬁcation, confounding, other
biases, or chance, the consistency of null ﬁndings suggests
that the absence of association is real.
The combined IARC/NIOSH pooled analysis comprised
21,863 male and female workers exposed to phenoxy
herbicides or chlorophenols from 32 cohorts of
manufacturing workers from Austria, Denmark, Finland,
Germany, Italy, the Netherlands, New Zealand, Sweden,
the United Kingdom, and the United States, and four
cohorts of sprayers from Australia, Canada, New Zealand,
and the United Kingdom (Supplemental Table S1) [17].
The period of employment and mortality follow-up varied
among countries; overall, they extended from 1939 to
1992. Exposure to TCDD was deﬁned as employment
during manufacture or spraying of 2,4,5-T, pentachloro-
phenol, or other potentially contaminated compounds, or
employment in plants with documented exposure through
biomonitoring (data available for 573 workers from 10
cohorts) or environmental measurements. Published mean
serum TCDD levels in subsets of workers included in the
IARC/NIOSH pooled analysis and controls are shown in
Table 6; these data demonstrate that phenoxy herbicide and
chlorophenol production workers and sprayers experienced
higher TCDD exposure than the population at large.
Overall, 13,831 workers from 28 cohorts (63.3 %) were
classiﬁed as exposed to TCDD (73 % manufacturing
workers and 27 % sprayers; 63 % from the IARC study
and 37 % from the NIOSH study), and 7,553 workers
(34.5 %) were classiﬁed as unexposed to TCDD (479
workers from a UK plant [2.2 %] could not be classiﬁed as
to TCDD exposure). The SMR for prostate cancer was 1.11
(0.81–1.50; 43 deaths) among exposed workers and 1.10
(0.71–1.62; 25 deaths) among unexposed workers
(Table 3; Figure S3). Prostate cancer results by duration of
employment, time since ﬁrst employment, or other indirect
indicators of exposure were not reported. Similarly, sepa-
rate results on herbicide manufacturers and sprayers were
not reported for prostate cancer. The original IARC pooled
analysis comprised 13,482 workers from 20 cohorts of
production workers and sprayers exposed to phenoxy her-
bicides and chlorophenols [129]. A total of 30 deaths from
prostate cancer were observed (SMR = 1.11 [0.75–1.58]);
no results were reported according to TCDD exposure. In
the original NIOSH pooled analysis, comprising 5,172
Table 6 Mean serum TCDD levels in groups of workers included in the IARC/NIOSH pooled analysis [17] and controls
Country Exposed workers Unexposed controls References
N, type Mean (ppt) N, type Mean (ppt)
Austria 9 PC 389 17 O *14 Neuberger et al. (130)
Germany 20 P 141
a – – Flesch-Janys et al. [131]
Germany 20 PC 402
a – – Manz et al. [132]
New Zealand 9 Sp 53 9 O 6 Smith et al. [133]
Sweden 5 P 17 5 O 2 Littorin et al. [134]
United States 253 P 233 79 S 2 Fingerhut et al. [135]
P, production workers; C, chloracne patients; Sp, sprayers; S, workers from same plants as exposed workers; O, workers from other plants than
exposed workers
a Modeled TCDD level at the end of employment
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(0.71–1.95; 17 deaths) in the whole cohort and 1.52
(0.70–2.90; 9 deaths) in the group of 1,520 workers with
one or more years of employment [135].
A subsequent analysis of the NIOSH pooled study [136]
provided results for mortality up to 1993, as compared with
1987 in the combined IARC/NIOSH analysis. This analysis
comprised 5,132 workers employed in 12 plants, all of
whom were considered exposed to TCDD. The SMR for
prostate cancer, based on 28 deaths, was 1.17 (0.78–1.68)
(Table 3; Figure S3).
Collins et al. [137, 138] reported two analyses of
workers employed in one of the plants included in the
NIOSH pooled analysis. The ﬁrst analysis [137] included
773 male pentachlorophenol manufacture workers exposed
to TCDD. The period of follow-up was not speciﬁed.
Serum TCDD levels were available for 128 workers and
were used to model TCDD exposure for the whole study
cohort. The SMR for prostate cancer in the whole cohort
was 1.0 (0.4–1.9), based on eight deaths (Table 3; Figure
S3). When workers were categorized in tertiles according
to estimated TCDD exposure, SMRs were 0.8 (0.1–2.9) for
low exposure (\0.7 ppt-years; 2 deaths), 0.6 (0.1–2.4) for
medium exposure (0.7–3.99 ppt-years; 2 deaths), and 1.4
(0.4–3.6) for high exposure (C4.0 ppt-years; 4 deaths). The
estimated RR of prostate cancer death per ppt-year was
1.002 (0.962–1.045). The second analysis [138] included
1,615 trichlorophenol workers with potential TCDD
exposure, including 196 pentachlorophenol workers who
presumably were also included in the ﬁrst analysis. As in
the ﬁrst analysis, TCDD exposure was modeled based on
serum levels, which were available for 280 workers. After
excluding pentachlorophenol workers, there were 20 deaths
from prostate cancer through 2003 (SMR = 1.5 [0.9–2.4]).
The RR of prostate cancer death per ppb-year increase in
cumulative estimated TCDD level was 1.013 (0.989–1.038;
P = 0.29).
A further analysis included 2,122 workers at four pen-
tachlorophenol production plants that were part of the
NIOSH pooled study [139]. A subcohort of 720 workers
involved in trichlorophenol production was considered
exposed to TCDD. In a follow-up through 2005, eight
deaths from prostate cancer were observed among the
exposed workers (SMR = 1.03 [0.45–2.04]), whereas 18
prostate cancer deaths were observed among the unexposed
(SMR = 0.98 [0.58–1.55]) (Table 3; Figure S3).
‘t Mannetje et al. [140] extended to 2000 the follow-up
of two cohorts from New Zealand included in the IARC
pooled analysis (1,025 production workers and 703
sprayers). The SMR for prostate cancer was 0.37
(0.01–2.08; 1 death) among production workers and 0.60
(0.07–2.16; 2 deaths) among sprayers (Table 3; Figure S3).
The cohort study of manufacturing workers was expanded
by McBride et al. [141, 142]. A ﬁrst report [141] included
1,754 workers employed in the manufacturing plant
between 1969 and 2003, with mortality follow-up through
2004. A total of three deaths from prostate cancer were
observed (SMR = 0.54 [0.11–1.56]). All three deaths
occurred among workers with less than three months of
employment (SMR in this group = 0.62 [0.13–1.82]; 0.8
expected prostate cancer deaths among workers with
longer duration of employment). The second analysis [142]
was restricted to 1,599 workers employed between 1969
and 1988, when 2,4,5-T was used and exposure to TCDD
was possible, with mortality follow-up through 2004. A
total of 1,134 workers were classiﬁed as exposed to TCDD,
and 465 workers were considered unexposed. Cumulative
TCDD levels were estimated based on serum levels
available for 346 workers. Three deaths from prostate
cancer were observed in this cohort (presumably the same
deaths reported in [141]); one death was among exposed
workers (SMR = 0.2 [0.0–1.2]) and two deaths were
among unexposed workers (SMR = 1.9 [0.2–6.7]). Results
according to estimated cumulative TCDD exposure were
not reported for prostate cancer.
The mortality of 2,106 male production workers
employed in two Dutch plants included in the IARC pooled
study was updated to 2006 [143]. A total of 539 workers in
factory A and 411 workers in factory B were classiﬁed as
exposed to TCDD based on either their history of
employment in selected departments (or having entered
them on a regular basis) or exposure to an accident that
occurred in 1963 in factory A. The remaining 482 workers
in factory A and 626 workers in factory B were classiﬁed
as unexposed. The RR of prostate cancer for TCDD
exposure was 2.93 (0.61–14.1) in factory A (based on six
deaths among the exposed and two deaths among the
unexposed) and 2.68 (0.48–14.9) in factory B (based on
four deaths among the exposed and two deaths among the
unexposed) (Table 3; Figure S3). Four out of the six
exposed cases in factory A were present during the 1963
accident. Boers and colleagues [146] extended this analysis
by including estimated TCDD exposure based on plasma
measurements available for 187 workers. The RR of
prostate cancer per log unit of TCDD (with a 10-year lag)
was 1.08 (0.79–1.49). In this analysis, all workers in fac-
tory B were considered unexposed to TCDD, and when the
analysis was restricted to factory A, the RR per lagged log
unit of TCDD level was 1.29 (0.85, 1.94).
The mortality follow-up of one of the plants from Ger-
many included in the IARC pooled study was extended to
2007 [144]. The cohort included workers ever employed
between 1952 and 1984, when the plant was closed. Causes
of death of deceased cohort members were coded by a
study pathologist; expected deaths were calculated based
on regional rates. Among 1,191 male workers, a total of 19
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[0.82–2.13]) (Table 3; Figure S3). Cumulative TCDD
exposure was estimated on the basis of serum levels on a
subset of workers, but results on prostate cancer were not
reported according to estimated TCDD level.
TheonlygroupofworkersnotincludedintheIARCorthe
NIOSH pooled analysis isacohortof243male workerswho
were involved between 1953 and 1969 in clean-up, repair,
maintenance, or demolition activities at a German plant
where an accident entailing release of TCDD occurred in
1953 [145]. Serum TCDD level was available for all cohort
members. Follow-up for mortality and cancer incidence
covered the period 1953–1992. No deaths from prostate
canceroccurredinthecohort(SMR = 0[0–1.9]),whilefour
incident cases were observed (SIR = 1.1 [0.3–2.8])
(Table 3; Figure S3). When workers were categorized
according to serum TCDD level, the SIR was 2.5 (0.5–7.4; 3
cases) in the low-exposure category (\0.1 lg/kg body
weight), 1.1 (0.0–5.9; 1 case) in the medium-exposure cat-
egory (0.1–0.99 lg/kg body weight), and 0.0 (0.0–2.5; 0
cases) the high-exposure category (C1 lg/kg body weight).
Subsets of workers who developed chloracne, indicating
high TCDD exposure, were identiﬁed in the NIOSH pooled
cohort (630 workers) [136] and in the German accident
cohort (113 workers) [145]. However, no results on risk of
prostate cancer were reported for these groups of workers.
Two other studies provided limited information on
prostate cancer risk associated with potential occupational
exposure to TCDD-contaminated herbicides. In the Agri-
cultural Health Study, a cohort of 55,332 male pesticide
applicators from Iowa and North Carolina, no association
was found between self-reported use of 2,4,5-T (or 2,4-D)
and risk of prostate cancer, based on 566 cases after a mean
follow-up period of 4.3 years (detailed results not reported)
[147]. In a population-based case–control study in Western
Australia, self-reported exposure to phenoxy herbicides
was not associated with risk of prostate cancer (OR = 1.00
[0.61–1.63]; 40 exposed cases) [148].
In summary, although a formal combination of results is
complicated by the overlap among reports, studies of manu-
facturers and sprayers of TCDD-contaminated herbicides
consistentlyindicatenosigniﬁcantincreaseinriskofprostate
cancer.Thisconclusioncomportswiththatofameta-analysis
of 20 cohort studies of phenoxy herbicide manufacturing
workers published through 2003, in which the combined
SMR for prostate cancer was 1.16 (0.85–1.57) [149]. Limi-
tations of the available data include the fact that most studies
reportedonlyresultsforprostatecancermortalityandthatthe
number of workers with high documented exposure is rela-
tively small. Workers with presumably different levels of
TCDD exposure were combined for analysis, resulting in
some degree of exposure misclassiﬁcation. Despite these
limitations, a substantial proportion of manufacturers and
sprayers included in these cohorts did experience consider-
ablyhigherexposuretoTCDDthanthegeneralpopulation,as
demonstratedbytheserumTCDDlevelsmeasuredinseveral
subsets of workers. Thus, the results of these studies provide
solid evidence against a signiﬁcant positive association
between TCDD or herbicides contaminated with TCDD,
including 2,4,5-T, and prostate cancer.
Studies of the Seveso industrial accident
Part ofthe population living insixItalian municipalities was
exposed to TCDD as a result of an accident in a trichloro-
phenol production plant in Seveso in 1976. Several reports
on cancer mortality or incidence in this area have been
published; the most recent analyses are based on follow-up
for cancer mortality through 2001 [150] and cancer inci-
dence through 1996 [151]. The design and results of these
studies are summarized in Table 4, and results are shown in
Figure S3.
The exposed group was divided among those living in
1976 (or migrating during 1976–1985) in zone A, with the
highest exposure (median serum TCDD level in
1976 = 447.0 ppt); zone B, with intermediate exposure
(median serum TCDD = 94.0 ppt); and zone R, with low
exposure (median TCDD level = 48.0 ppt). The reference
group comprised the remaining areas of the six munici-
palities, as well as ﬁve surrounding municipalities. Cancer
incidence was based on record linkage with the regional
population-based cancer registry, and the mortality follow-
up was based on vital status information obtained from the
municipalities of residence and on cause of death obtained
from the regional statistical ofﬁce.
The cancer incidence analysis was based on people
living in the contaminated area (352 men in area A, 2,471
men in zone B, 15,715 men in zone R, and 88,349 men in
the reference zone) [151]. This analysis included zero cases
of prostate cancer in zone A (expected cases not reported,
but estimated as approximately 1 case, based on the rates in
zones B and R), seven cases in zone B (RR = 0.94
[0.45–1.99]), and 39 cases in zone R (RR = 0.75
[0.54–1.05]) (Table 4; Figure S3).
The cancer mortality analysis included also those indi-
viduals who were born or immigrated into the study area
between 1976 and 1985 (390 men in area A, 3017 men in
area B, 19,199 men in area R, and 139,516 men in the
reference area) [150]. The observed deaths from prostate
cancer were one in zone A (RR = 0.87 [0.12–6.17]), eight
in zone B (RR = 0.88 [0.44–1.77]), and 65 in zone R
(RR = 1.06 [0.81–1.38]) (Table 4; Figure S3).
In summary, there is no evidence of an increased risk of
prostate cancer in the community exposed to the Seveso
accident with follow-up extending over 20–25 years. While
the number of individuals in the zone with highest exposure
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error based on geographic zone of residence instead of
individual serum TCDD level, the results in the combined
zones A and B are not compatible with a signiﬁcant associ-
ation between TCDD exposure and prostate cancer.
A recent meta-analysis of cohort studies of TCDD and
prostate cancer calculated a meta-SMR of 1.26 (1.00–1.57)
based on 13 militaryand occupational cohorts (one of which
reportedanSIR)andameta-RRof1.04(0.84–1.28)basedon
four military and community cohorts [152]. This meta-ana-
lysis had a number of important ﬂaws, such as the omission
of several relevant articles [17, 137, 142, 144, 146, 151], the
selection of results from some exposed subcohorts but not
others[140],theequalweightingofRRsorSIRsforsubjects
with low, medium, or high TCDD exposure within a given
cohort [145, 150], and the conﬂation of incidence and mor-
tality data and heterogeneous military, occupational, and
environmental exposure levels. Overall, this study offers no
additional insight into the relationship between TCDD and
prostate cancer risk. This study also demonstrates that meta-
analysis may be poorly suited for synthesizing results of
observational studies with heterogeneous settings, methods,
and exposure levels that require careful interpretation of
individualandcollectiveresultsforcausalinference[59,60].
Discussion
The best available epidemiologic studies of exposure to
Agent Orange/TCDD show no signiﬁcant association with
prostate cancer incidence or mortality. Speciﬁcally, the only
two studies of Vietnam veterans with exposure to Agent
Orange conﬁrmed by elevated serum TCDD levels—
namely, the Air Force Health Study and the Army Chemical
Corps study—found no signiﬁcant increase in prostate can-
cer incidence [64, 73] or mortality [62, 84, 87] in exposed
veterans overall. Likewise, occupational cohort studies of
industrial exposure to TCDD-contaminated herbicides and
studies of the Seveso community cohort—considered by
IARC to be the most informative epidemiologic studies for
evaluating the carcinogenic effects of TCDD in humans—
consistently found no signiﬁcant association with prostate
cancer incidence or mortality [17, 136–145, 150, 151]. RR
pointestimatesinthesestudieswerefairlyevenlydistributed
above, below, and at the null value of 1.0, with no evidence
that subgroups with greater exposure experienced a higher
risk. The Air Force Health Study main analyses, the Army
Chemical Corps study, the occupational cohort studies, and
the Seveso cohort study are accorded the greatest weight in
evaluation of the overall epidemiologic literature on Agent
Orange/TCDD exposure and prostate cancer because these
are the only studies in which subjects designated as exposed
were conﬁrmed to have elevated serum levels of TCDD.
In his well-known and widely implemented guidelines
for the evaluation of potential causal associations, Sir
Austin Bradford Hill speciﬁed that the guidelines were
intended to be applied to ‘‘an association between two
variables, perfectly clear-cut and beyond what we would
care to attribute to the play of chance. What aspects of that
association should we especially consider before deciding
that the most likely interpretation of it is causation?’’ [153].
In the absence of such a ‘‘clear-cut’’ association—indeed,
in the presence of considerable evidence indicating no
association, as in the case of Agent Orange/TCDD and
prostate cancer—characteristics such as the strength, con-
sistency, speciﬁcity, temporality, exposure–response gra-
dient, plausibility, and coherence of a potential exposure-
disease relationship are not strictly applicable. Nonethe-
less, based on the most informative epidemiologic studies,
we can state that the apparent association is not strong, that
results across studies are consistent in demonstrating the
absence of any increase in prostate cancer risk, and that
there is no positive exposure–response gradient.
The null results are also coherent with toxicological data
from experimental animal studies. Speciﬁcally, although
TCDDpromotesavarietyoftumorsindifferentstrainsofrats,
mice, and hamsters through a non-genotoxic mechanism
believedtoinvolvetheAhreceptor[11,12,14–16],benignor
malignanttumorsoftheprostatearenotamongthoseobserved
in excess in experimental animals. 2,4,5-T itself, in the
absence of TCDD, has been found not to increase tumor
incidence in experimental rodents [154]. Similarly, 2,4-D—
the other ingredient of Agent Orange—demonstrates no
apparentoncogeniceffectinexperimentalanimals[155–157].
Thus, animal evidence supports the results of epidemiologic
studies showing no signiﬁcant association between Agent
Orange or TCDD exposure and prostate cancer risk.
The only studies that found a signiﬁcant positive associ-
ation with prostate cancer were those in which the exposure
under evaluation was self-reported or geography-based
Agent Orange exposure [33, 34, 92, 94] or Vietnam military
service overall in comparison with the general population
[63, 110–116, 118–120]; or, in the Air Force Health Study,
where the analysis was restricted to veterans with a shorter
duration of military service or where Ranch Hands who
served exclusively in Vietnam were compared with subjects
who served exclusively outside of Vietnam [63]. As dis-
cussed earlier, self-reported and proximity-based Agent
Orange exposure estimates are not closely correlated with
serum TCDD levels [82, 97]. Therefore, profound exposure
misclassiﬁcation, combined with potential selection bias,
largely invalidates the ﬁndings of these studies, which can-
not contribute useful information about the association
between Agent Orange/TCDD exposure and prostate cancer
risk. Confounding by diagnostic intensity, particularly PSA
testing, is a major concern in studies that compare Vietnam
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group analyses of the Air Force Health Study, where chance
(given probable testing of numerous subgroups) is another
important potential explanation for the reported associa-
tions. Taken together with the null results of the more reli-
ablestudiesidentiﬁedabove,thepositiveﬁndingsfromthese
selected studies of veterans are more likely to be spurious
than valid.
In conclusion, studies of Vietnam veterans, herbicide
manufacturers or sprayers, and community members known
tobehighly exposedtoAgentOrange orTCDD consistently
demonstrate the absence of a signiﬁcant increase in prostate
cancer incidence or mortality in these groups. Several bias-
prone studies of veterans with poorly characterized Agent
Orange exposure reported an excess of prostate cancer, but
such ﬁndings cannot reliably be attributed to an effect of
Agent Orange/TCDD rather than confounding or bias.
Toxicological ﬁndings in animals are also coherent with the
absence of a carcinogenic effect of TCDD on the prostate.
Overall, the scientiﬁc evidence establishes no causal asso-
ciation between exposure to Agent Orange or TCDD and
prostate cancer in humans. However, the most rigorously
designed studies may lack sufﬁcient power to determine
whether RRs of the magnitude generally reported (approx-
imately 0.3–3.0) were statistically signiﬁcantly different
from 1.0. Development of more sensitive biomarkers of past
exposure to Agent Orange or TCDD could enable larger
studies to rule out a causal association more conclusively.
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